MedTrace Logo

Hearing for Learning Initiative - a Health Facilitator Model for Otitis Media

NCT03916029 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2025-05-21

No results posted yet for this study

Summary

The Hearing for Learning Initiative is a stepped-wedge cluster randomised controlled trial. The HfLI will implement and rigorously evaluate an innovative community-based service-enhancement model of ear and hearing health, in partnership with participating communities and health and education services.

This initiative will address the following research question: In urban, rural and remote Aboriginal communities in the Northern Territory, does employment, training and integration of local Ear and Hearing Clinical and Education Support Officers into health and education services (the Hearing for Learning initiative), compared to current practice, increase the proportion of children who receive an ear assessment, reduce the prevalence of ear and hearing problems and improve education outcomes of Aboriginal and Torres Strait Islander children, during a four year trial period?

Conditions

  • Otitis Media
  • Conductive Hearing Loss

Interventions

BEHAVIORAL

facilitator

Training and employment of community members to assist the diagnosis and management of otitis media

Sponsors & Collaborators

  • Australian Government Department of Health and Ageing

    collaborator OTHER_GOV

  • Northern Territory Government of Australia

    collaborator OTHER_GOV

  • Menzies School of Health Research

    lead OTHER

Principal Investigators

  • Amanda Leach, PhD · Menzies School of Health Research

  • Kelvin Kong, MBBS · Newcastle University

  • Peter S Morris, MBBS, PhD · Menzies School of Health Research

  • Alan Cass, MBBS, PhD · Menzies School of Health Research

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
1 Week
Max Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-02-03
Primary Completion
2024-06-30
Completion
2024-12-31

Countries

  • Australia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03916029 on ClinicalTrials.gov